Private Equity, Public Markets
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Employees, Human Rights and Working Conditions Responsibility For
SUSTAINABILITY AND RESPONSIBLE OWNERSHIP – EXTRACTS FROM THE ANNUAL REPORT 2016 This is Ratos Ratos is an investment company that acquires, develops and divests primarily unlisted Nordic companies. The common denominator for the companies that Ratos acquires is a clear development potential with focus on growth and profitability. VISION Ratos will be the best at developing companies in the Nordic region INVESTMENT STRATEGY Ratos invests mainly in unlisted medium-sized Nordic which Ratos and the companies can together identify and companies with clear development potential. The enter- then realise a potential. Ratos’s investment interval spans prises should have an established business model through from SEK 250m up to SEK 5 billion in equity. RATOS’S BUSINESS MODEL ACQUISITIONS DEVELOPMENT DIVESTMENT Medium-sized companies Ratos’s goal is to generate value by developing Ratos has a flexible ownership with clear potential for successful companies. We lend the horizon and stays on as owner 2. development, tested business innovativeness, experience, expertise, Foc as long as we contribute to the us models and employees with contacts and capital needed to real- s cr o development of the company e ea n lu t strong drive are interesting ise the potential of the companies a io v and meet our return target. V a . n l u 1 investment opportunities for in which we invest. Our primary e We endeavour to combine long- Ratos. Ratos primarily invests focus is to work together with term sustainable growth with the in unlisted companies in the the companies’ executive DEVELOPMENT highest possible return. MODEL e Nordic countries and ideally management to increase growth c 4 n . -
Private Equity in Sweden
PRIVATE EQUITY IN SWEDEN An analysis of the private equity industry in Sweden and two case studies on individual companies’ competitive strategy JOHAN MATTISSON MASTER THESIS LUND UNIVERSITY, 2017 Abstract Private equity is a growing global phenomena and private equity companies have become a major force in many of Sweden’s industries. These companies own portfolio companies which together employs around 190 000 people and have an annual revenue of over 318 billion SEK. The purpose of this thesis was to describe and analyze the Swedish private equity industry and individual companies’ competitive strategy to increase value of portfolio companies and to attract capital. The methodical approach of this thesis was qualitative and abductive. Only public data was used bar the two interviews that was conducted with the case companies. The theoretical framework for the industry analysis was Porters five forces. The case companies were analyzed on the corporate, business and operational levels of strategy. A resource based view was used to further analyze the case companies’ strategic capabilities. The main findings from the industry analysis was that the vast majority of investors in Swedish private equity funds are made by professional institutions and a large amount of the investments were of international origin. The large pool of investors makes it easier for Swedish private equity companies to attract capital. The number of new private equity funds have been declining since 2007 but at the same time the average fund size has grown. There are many differentiating factors between private equity companies. This differentiation is beneficial for the private equity companies as they become less commoditized from the viewpoint of an investor. -
Private Equity 05.23.12
This document is being provided for the exclusive use of SABRINA WILLMER at BLOOMBERG/ NEWSROOM: NEW YORK 05.23.12 Private Equity www.bloombergbriefs.com BRIEF NEWS, ANALYSIS AND COMMENTARY CVC Joins Firms Seeking Boom-Era Size Funds QUOTE OF THE WEEK BY SABRINA WILLMER CVC Capital Partners Ltd. hopes its next European buyout fund will nearly match its predecessor, a 10.75 billion euro ($13.6 billion) fund that closed in 2009, according to two “I think it would be helpful people familiar with the situation. That will make it one of the largest private equity funds if Putin stopped wandering currently seeking capital. One person said that CVC European Equity Partners VI LP will likely aim to raise 10 around bare-chested.” billion euros. The firm hasn’t yet sent out marketing materials. Two people said they expect it to do so — Janusz Heath, managing director of in the second half. Mary Zimmerman, an outside spokeswoman for CVC Capital, declined Capital Dynamics, speaking at the EMPEA to comment. conference on how Russia might help its reputation and attract more private equity The London-based firm would join only a few other firms that have closed or are try- investment. See page 4 ing to raise new funds of similar size to the mega funds raised during the buyout boom. Leonard Green & Partners’s sixth fund is expected to close shortly on more than $6 billion, more than the $5.3 billion its last fund closed on in 2007. Advent International MEETING TO WATCH Corp. is targeting 7 billion euros for its seventh fund, larger than its last fund, and War- burg Pincus LLC has a $12 billion target on Warburg Pincus Private Equity XI LP, the NEW JERSEY STATE INVESTMENT same goal as its predecessor. -
Gimv Invests in Biopharmaceutical Company Complix
Antwerp, 26 June 2013, 7:30 AM CET Gimv invests in biopharmaceutical company Complix Gimv and Gimv managed Biotech Fonds Vlaanderen invest in Complix, a biopharmaceutical company focused on the discovery and development of novel therapeutics based on its AlphabodiesTM platform. This investment is part of a total Series B equity financing round of EUR 12 million from a syndicate of important life sciences investors, co-led by new investors Gimv and Edmond de Rothschild Investment Partners. Complix is a biopharmaceutical company developing a pipeline of therapeutics, called AlphabodiesTM, mainly focused on oncology and autoimmunity. Alphabodies are a revolutionary class of protein therapeutics that combine the attractive features of antibodies, including high target specificity and affinity, with the benefits from small chemical drugs such as extreme stability and their capacity to penetrate cells. As a result of these unique features, Alphabodies can tackle a broad range of diseases where treatment options today are limited or non-existent. Complix is headquartered in Hasselt (Belgium) at the Life Sciences incubator BioVille, and has research facilities in Ghent (Belgium) and in Luxembourg. Since its founding in 2008 Complix has raised a total of EUR 26 million in funding, including the EUR 12 million capital round announced today. This financing round will be used to develop a first set of therapeutic Alphabodies for treatment of cancer and auto- immune indications, and to further develop and validate the company’s unique Alphabody platform. Mr Patrick Van Beneden, Partner at Gimv, comments: “We are very excited by the Complix opportunity because it perfectly fits in our Health & Care platform strategy for biotech investments. -
LAZARD GROUP LLC (Exact Name of Registrant As Specified in Its Charter)
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-126751 (Commission File Number) LAZARD GROUP LLC (Exact name of registrant as specified in its charter) Delaware 51-0278097 (State or Other Jurisdiction of Incorporation (I.R.S. Employer Identification No.) or Organization) 30 Rockefeller Plaza New York, NY 10020 (Address of principal executive offices) Registrant’s telephone number: (212) 632-6000 Securities Registered Pursuant to Section 12(b) of the Act: None Securities Registered Pursuant to Section 12(g) of the Act: None Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. -
Annual Report 2018 - 2019
ANNUAL REPORT 2018 - 2019 ANNUAL REPORT 2018 - 2019 LEADING OUR PORTFOLIO COMPANIES FOR THE BENEFIT OF OUR ECONOMY. CONTENTS 1. Message from Chairman and CEO 5 2. Business model and investment strategy 9 3. Value creation starting from 4 central themes 23 4. Results and activity report 35 5. Key figures 41 6. Share and shareholders 45 7. Corporate Governance Statement 49 8. Annual Accounts 77 9. Contact 141 INVESTMENT PORTFOLIO EUR 1.1 BILLION OUR 55 PORTFOLIO COMPANIES JOINTLY REALISE A TURNOVER OF MORE THAN EUR 2.75 BILLION AND EMPLOY 14 000 PROFESSIONALS FOCUS ON VALUE CREATION FROM 4 PLATFORMS CONNECTED HEALTH SMART SUSTAINABLE CONSUMER & CARE INDUSTRIES CITIES 4 OFFICES WITH MULTIDISCIPLINARY TEAMS: ANTWERP, PARIS, THE HAGUE, MUNICH 39 YEARS’ EXPERIENCE IN PRIVATE EQUITY OVER THE LAST 5 YEARS INVESTED IN 932 EUR MILLION 46 COMPANIES PROCEEDS FROM 1 520 EUR MILLION 48 EXITS MESSAGE FROM CHAIRMAN AND CEO1 6 ANNUAL REPORT 2018-2019 The world around us is changing at an incredible pace. Last year we were still talk- ing about an improving economy that had moved up several gears; today, barely a year later, we see this economic upswing under threat from various geopolitical and macroeconomic factors. Trade relations are more difficult, the power posi- IMPACT: MEETING CRUCIAL tions and therefore also the relationships between CHALLENGES TOGETHER the major world economic powers are shifting, as evidenced by the never-ending story of Brexit. Gimv goes looking for the market leaders of Last year, climate and the environment concerns tomorrow, together with which it can make a vi- topped the political and economic agenda, calling tal difference, year after year. -
Investment Companies 13 October 2011
www.numiscorp.com Marketing Communication Investment Companies 13 October 2011 Research Listed Private Equity Charles Cade +44 (0)20 7260 1327 What are the True Costs? [email protected] George Crowe Transparency has improved significantly within the listed Private Equity sector in +44 (0)20 7260 1280 recent years, and valuation methodologies have become more standardised with [email protected] the adoption of fair value accounting. This has made it much easier for investors Ewan Lovett-Turner to differentiate between listed Private Equity funds (LPEs) on the basis of their +44 (0)20 7260 1299 portfolio characteristics and balance sheet risk. However, it is still far from [email protected] straight-forward to compare the costs of LPEs in terms of fees and finance Colette Ord charges. In contrast, private equity Limited Partnerships (LPs) have relatively +44 (0)20 7260 1290 standardised fee arrangements and simple balance sheets with no debt. [email protected] In part, these complications reflect the evergreen nature of most LPEs, whereby they Sales offer exposure to a range of investment vintages. As a result, management fees are James Glass typically charged on the value of assets rather than initial commitments. Listed funds +44 (0)20 7260 1369 also face additional operating costs such as directors‟ fees and administration, and often [email protected] adopt more diverse investment strategies, including directs, co-investment and funds. Chris G00k Some have feeder fund structures, with fees charged indirectly by the manager, while +44 (0)20 7260 1378 others are self-managed and pay staff costs rather than a defined management fee. -
Longleaf Partners International Fund Commentary 2Q21
July 2021 Longleaf Partners International Fund Commentary 2Q21 Longleaf Partners International Fund added 1.19% in the quarter and 8.00% year-to- date, trailing the MSCI EAFE Index’s 5.17% and 8.83% for the same periods. US markets continued the monetary liquidity fueled run to ever sillier valuation levels, while non-US lagged relatively. The majority of our holdings were positive in the quarter. The Fund’s exposure to China and Hong Kong (including Netherlands-listed Prosus, whose business is driven by the Chinese consumer) was the biggest geographic headwind. FX was a moderate contributor to the Fund, as well as the MSCI EAFE index. Despite relative underperformance, it was a solid period for value per share growth at our holdings. “Value” had a (we believe temporary) pullback vs. “growth” in the second quarter on the back of lower interest rates and various other factors. Over the last year, we have seen interest rate consensus go from “low rates forever” for most of 2020 to “rates are definitely going up” in February/March of 2021 to what now feels like magical goldilocks thinking for growth stocks in the 1-2% US 10-year range. While we cannot predict precisely what rates will do in the near term, we welcome increased volatility on this all- Average Annual Total Returns for the Longleaf Partners International Fund (6/30/21): Since Inception (10/26/98): 7.45%, Ten Year: 4.50%, Five Year: 10.64%, One Year: 34.82%. Average Annual Total Returns for the MSCI EAFE (6/30/21): Since Inception (10/26/98): 5.62%, Ten Year: 5.89%, Five Year: 10.28%, One Year: 32.35%. -
GP Investments
1 GP Investments Earnings Release Fourth Quarter 2020 Earnings Release 2Q18 2 2020 highlights March 31, 2021 – This release reports the 4Q20 and full-year results of GP Investments, Ltd. (‘GP’) [B3: GPIV33], a leader in private equity and alternative investments. 2020 was a challenging year worldwide; and for GP Investments this was no different. At the beginning of the Covid-19 pandemic, most of the companies in GP’s portfolio that have physical premises had to close facilities or operate under restrictions. Brick-and-mortar stores had to be closed, restaurants had to depend mostly on delivery and take-out, and many businesses had to be reinvented fast. In March, GP moved 100% of its team members, across all its offices, to remote working, following procedures in its Business Continuity Plan. The transition to a work-at-home model was seamless, with no interruptions in our activities, and we have continued to leverage multiple digital technologies to enable our teamwork. The results reported by GP Investments in 2020 reflected the volatility of the financial markets, and the economic impacts of the pandemic. In the 4th quarter of 2020, GP posted net income of USD 33.8 million, which was driven by increases in the share prices of our listed companies – primarily Centauro – as well as the positive impact of the temporary BRL appreciation. Nevertheless, for the full year, mark-to-market adjustments in the companies in the portfolio have translated into significant net unrealized losses, which together with the rapid devaluation of the Brazilian Real have led to a total net loss of USD (91.8) million in 2020. -
4Oct200722045121 1Dec200517045043
4OCT200722045121 This prospectus (the ‘‘Prospectus’’) relates to the initial offering (the ‘‘Offering’’) to subscribe for up to A75 million of new common shares in Ablynx NV (the ‘‘Company’’ or ‘‘Ablynx’’), with VVPR strips (the ‘‘VVPR Strips’’). This amount of New Shares with VVPR Strips may be increased by up to 15 per cent, to an amount of A86.25 million (the ‘‘Increase Option’’, the new shares initially offered and the shares offered as a result of the possible exercise of the Increase Option jointly being referred to as the ‘‘New Shares’’). Any decision to exercise the Increase Option will be announced, at the latest, on the date the Offer Price is announced. JPMorgan and KBC Securities (the ‘‘Joint Global Coordinators’’) will be granted an over-allotment option by the Company (the ‘‘Over-allotment Option’’), exercisable as of the listing date (the ‘‘Listing Date’’) and until 30 days thereafter, corresponding to up to 15 per cent of the New Shares subscribed for in the Offering for the sole purpose of allowing the Joint Global Coordinators to cover over-allotments, if any. The existing shares covered by the Over-allotment Option (the ‘‘Additional Shares’’ and, together with the New Shares, the ‘‘Offered Shares’’) and the New Shares issued upon exercise of the Over-allotment Option, if any, will not have a separate VVPR Strip. The Offered Shares are offered to the public in Belgium (including to employees, consultants and independent directors of the Company in Belgium) and, pursuant to a private placement, to institutional investors, both within and outside Belgium and to employees, consultants and independent directors of the Company outside Belgium. -
Private Equity Spotlight September 2007 / Volume 3 - Issue 9
Private Equity Spotlight September 2007 / Volume 3 - Issue 9 www.preqin.com Welcome to the latest edition of Private Equity Spotlight, the monthly newsletter from Preqin, providing insights into private equity performance, investors and fundraising. Private Equity Spotlight combines information from our online products Performance Analyst, Investor Intelligence & Funds in Market. Feature Article page 02 Investor Spotlight page 11 Private Equity Real Estate Still Booming but increased Know Your Investors competition is set to make fundraising conditions considerably This month we examine harder in 2008. We examine the reasons behind the industry’s how the typical make up of continued growth, with forecasts and predictions for the investors in closed funds coming year. varies with size and type. We show how effectively page 06 Performance Spotlight targeting the right investors is essential in order to raise How Good Are Your Benchmarks? Benchmarks are vital a fund as successfully and for a range of purposes, including strategic asset allocation, effi ciently as possible. Featuring information from the recently tactical investment decisions, and competitive comparisons. upgraded Investor Intelligence database. How can you be sure the benchmarks you use are as accurate as possible? Investor News page 16 Fundraising page 08 All the latest news on investors in private equity: This month’s Fundraising Spotlight examines the latest data for buyout and venture funds, and also takes an in-depth look • TRS has issued an RFP at mezzanine fundraising. -
ANNUAL REPORT 2016 Contents
R ATOS ANNUAL REPORT 2016 Contents REVIEW OF 1 The year in brief 2 This is Ratos CEO’s OPERATIONS 3 Ratos’s portfolio COMMENTS 4 4 CEO’s comments 6 2016 in 5 minutes 8 Vision, business concept, investment strategy and targets 10 Ratos as owner 15 Sustainable development 20 We at Ratos 24 Ratos share data 26 Companies overview COMPANIES 28 Aibel 29 airteam 30 Bisnode ACTIVE OWNERSHIP 31 DIAB 10 IN PRACTICE 32 GS-Hydro 33 Gudrun Sjödén Group 34 HENT 35 HL Display 36 Jøtul 37 KVD 38 Ledil 39 Nebula 40 Oase Outdoors 41 Plantasjen 42 Serena Properties 43 Speed Group 44 TFS SUSTAINABLE DEVELOPMENT 45 Financial statements – Contents 15 DIRECTORS’ 46 Directors’ report REPORT 50 Chairman’s letter 51 Corporate governance report 60 Board of Directors and CEO 62 Consolidated income statement 62 Consolidated statement of comprehensive income 63 Consolidated statement of financial position 64 Consolidated statement of changes in equity 65 Consolidated statement of cash flows 66 Parent company income statement 66 Parent company statement of comprehensive income 67 Parent company balance sheet 68 Parent company statement of changes in equity 69 Parent company cash flow statement ORGANISATION 70 Index to the notes 20 71 Notes to the financial statements 116 Auditor’s report 119 Additional information – Contents FURTHER 120 Five-year summary, Group INFORMATION 121 Definitions 122 GRI Index 124 Shareholder information OUR 26 COMPANIES The year in brief 2016 was an intensive year for Ratos. In total, five company acquisitions were made and agreements were signed for the full or partial divestment of four companies, while one IPO was carried out.